The pharma body also slashed the prices of 14 formulations and fixed the price of one for the first time.
The NPPA raised the prices of Soframycin by 7.99 per cent for a 20-gm pack to Rs 17.84 from Rs 16.52 and by 10 per cent for a 100-gm pack to Rs 72.90 from Rs 66.27.
Soframycin, a Rs 27-crore brand as per ORG figures, came to the Hoechst stable by virtue of its merger with Roussel India some years ago.
The pharma-pricing authority fixed the price of an anti-tuberculosis drug, Ticin, manufactured by Themis Chemicals based on the bulk drug rifampicin for the first time at Rs 498.41 for a pack of 60 tablets.
It also reduced the price of German Remedies' anti-bacterial Supristol by 1.99 per cent to Rs 8.85 from Rs 9.03 for a pack of 10 tablets. However, Supristol is not a significant brand for the company.
The price cut has been made in the range of 1.95-21.12 per cent for 11 formulations of the drug trimethoprim sulphamethoxazole (TMP-SMX). The highest downward revision has been made in the case of trimethoprim sulphamethoxazole tablets, whose prices were brought down by 21.12 per cent to Rs 10.16 from Rs 12.88.
More From This Section
The leading brands in the TMP-SMX category are Septran from Burroughs Wellcome, Bactrim from Nicholas Piramal, and Cipla's Ciplin.
NPPA also reduced prices of Ultrox tablet, manufactured by Ethnnol Ltd, by 5.47 per cent to Rs 9.51 from Rs 10.06 for a pack of six.